Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score (Q38387245)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 September 2016
edit
Language Label Description Also known as
English
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score
scientific article published on 22 September 2016

    Statements

    Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score (English)
    Florian Weissinger
    Hyun Cheol Chung
    Shao-Chun Chang

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit